Veracyte (VCYT) Tops Q1 EPS by 2c

Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $82.42 million versus the consensus estimate of $75.81 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins